Cardiac arrest is a sudden loss of blood flow resulting from the failure of the heart to effectively pump. Signs include loss of consciousness and abnormal or absent breathing. Some individuals may experience chest pain, shortness of breath, or nausea before cardiac arrest. If not treated within minutes, it typically leads to death.
This report contains market size and forecasts of Cardiac Arrest Treatment in Global, including the following market information:
Global Cardiac Arrest Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cardiac Arrest Treatment market was valued at 588 million in 2021 and is projected to reach US$ 693.8 million by 2028, at a CAGR of 2.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cardiac Arrest Treatment include Amgen, Inc., Pfizer, Inc., Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Abbott, Koninklijke Philips N.V., GE Healthcare and Physio-Control, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cardiac Arrest Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiac Arrest Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cardiac Arrest Treatment Market Segment Percentages, by Type, 2021 (%)
Drugs
Medical
Global Cardiac Arrest Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cardiac Arrest Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Independent Pharmacies
Others
Global Cardiac Arrest Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cardiac Arrest Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiac Arrest Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cardiac Arrest Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen, Inc.
Pfizer, Inc.
Johnson & Johnson
Novartis AG
Bristol-Myers Squibb Company
Abbott
Koninklijke Philips N.V.
GE Healthcare
Physio-Control, Inc.
Boston Scientific Corporation
Cardiac Science Corporation
Shenzhen Mindray Bio-Medical Electronics Co., Ltd
Bayer AG